Janssen COVID-19 Vaccine

Janssen COVID-19 Vaccine

On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. Emergency Use Authorization Status: Authorized Name: Janssen COVID-19 Vaccine Manufacturer: Janssen Biotech Inc.,a Janssen Pharmaceutical Company of Johnson & JohnsonAuthorized UseFor the prevention of coronavirus disease 2019 (COVID-19) for individuals 18 years of age and olderCommon Side EffectsThe most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects occurred within 1-2 days following vaccination and were mild to moderate in severity and lasted 1-2 days. Additional InformationTranslations of the Fact Sheet for Recipients and Caregivers

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!